查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829328

2025年全球干粉吸入器市场报告

Dry Powder Inhaler Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，干粉吸入器市场稳定成长，从2024年的212.5亿美元增加到2025年的221.8亿美元，复合年增长率为4.4%。这段历史时期的成长可归因于对永续建筑材料、文化保护和遗产修復的重新关注、绿色建筑实践的兴起、本地采购和社区参与，以及监管支持和建筑规范的完善。

预计未来几年干粉吸入器市场规模将稳定成长，到2029年将达到268.2亿美元，复合年增长率为4.9%。预测期内的成长可归因于对永续性的持续重视、全球都市化趋势、製造流程的进步、政府激励措施和政策以及全球经济因素。预测期内的主要趋势包括研发力度加大、对传统建筑技术的重新关注、材料技术的进步、建筑和设计趋势以及对永续建筑的监管支持。

干粉吸入器 (DPI) 是医疗设备，旨在将药物以干粉形式直接输送至肺部。它们主要用于治疗气喘和慢性阻塞性肺病(COPD) 等呼吸系统疾病。为了有效使用 DPI，使用者必须快速深吸，以确保药物到达肺部。

干粉吸入器主要分为单剂量吸入器和多剂量吸入器。单剂量吸入器将药物以干粉直接输送至肺部。这类设备有手动和电子两种形式，用于治疗气喘、慢性阻塞性肺病和囊肿纤维化等疾病。这类设备的终端使用者多种多样，包括医院、诊所、家庭护理机构和门诊手术中心。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供干粉吸入器市场统计数据，包括全球市场规模、各地区市场份额、竞争对手的市场份额、详细的干粉吸入器细分市场、市场趋势和商机，以及您在干粉吸入器行业取得成功所需的数据。本干粉吸入器市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年4.9%的预测成长率比我们先前对该市场的预测略有下降，下降了0.1%。下降的主要原因是美国与其他国家之间的关税影响。这可能会透过对来自英国和英国等主要地区的精密剂量计数器和呼吸驱动分散装置征收关税直接影响美国，从而可能损害呼吸系统药物输送，并增加慢性阻塞性肺病(COPD) 和气喘的治疗成本。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，影响可能会更加广泛。

呼吸系统疾病的日益流行预计将在未来几年推动干粉吸入器市场的成长。呼吸系统疾病涵盖了影响呼吸系统的多种疾病，包括各种肺部疾病。干粉吸入器透过将药物直接输送到最有效的肺部，在治疗气喘、慢性阻塞性肺病和囊肿纤维化等呼吸系统疾病方面发挥关键作用。这种方法为传统的呼吸系统疾病药物传递技术提供了一个很有前景的替代方案。例如，根据 2023 年 12 月发表在美国医学会医学杂誌 JAMA Network Open 上的一项研究，到 2050 年，全球慢性阻塞性肺病(COPD) 负担预计将达到近 6 亿例，患病率将增加 23%。值得注意的是，女性病例预计将增加 47.1%，而男性病例预计仅增加 9.4%。此外，这些病例大多发生在中低收入地区，预计到 2050 年，这些地区的盛行率将是高所得地区的两倍以上。因此，呼吸系统疾病盛行率的上升将极大地推动干粉吸入器市场的扩张。

预计空气污染水平的上升也将推动干粉吸入器市场的成长。空气污染以空气中各种污染物的浓度来衡量，会导致呼吸问题。干粉吸入器是缓解空气污染物加剧的症状和控制呼吸系统疾病的首选药物传递方式。 2022年，美国环保署报告称，美国排放到空气中的污染物数量约为6,600万吨。此外，2023年3月，IQAir报告称，伊拉克是2022年污染第二严重的国家，PM2.5浓度为80.1 μg/m3，是世界卫生组织年度PM2.5指导值的16倍。因此，预计空气污染水平的上升将推动干粉吸入器市场的成长。

干粉吸入器市场的关键参与者正专注于开发以毒蕈碱拮抗剂为特色的创新产品，用于治疗慢性阻塞性肺病(COPD)，同时扩大产品系列。毒蕈碱拮抗剂是阻断毒蕈碱乙酰胆碱受体的药物，用于治疗各种疾病，包括 COPD 和有机磷中毒。例如，2024 年 3 月，以开发和製造各种软包装解决方案而闻名的美国公司 Berry Global 在其 Pharma Pack 中推出了一种新型干粉吸入器。此吸入器专为改善 COPD 和气喘等呼吸系统疾病的药物输送而设计，为製药公司提供可客製化的解决方案。

2024年8月，美国药物输送专家阿普塔製药（Aptar Pharma）收购了Orbital Dry Powder Inhalers，收购金额未揭露。此次收购增强了阿普塔在呼吸系统药物传输领域的能力，尤其是在气喘和慢性阻塞性肺病（COPD）等疾病的治疗方面。 Orbital Dry Powder Inhalers以其创新的设计而闻名，可增强药物传递。此次收购符合阿普塔製药扩大产品组合、巩固其在呼吸治疗市场地位的策略。 Orbital Dry Powder Inhalers在印度的製药和医疗设备领域开展业务。

干粉吸入器市场包括干粉泡沫吸入器、思力华手持式吸入器、呼吸启动式吸入器、旋转吸入器、干粉吸入器和旋转式吸入器的销售。该市场的价值是指“出厂价”，即商品製造商或生产商销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球干粉吸入器：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球干粉吸入器市场：成长率分析
  • 全球干粉吸入器市场表现：规模与成长，2019-2024
  • 全球干粉吸入器市场预测：规模与成长，2024-2029年，2034年
  • 全球干粉吸入器：总目标市场（TAM）

第六章 市场细分

  • 全球干粉吸入器市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 单剂量吸入器
  • 多剂量吸入器
  • 全球干粉吸入器市场：按功能、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 手动吸入器
  • 数位操作吸入器
  • 全球干粉吸入器市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 气喘
  • 慢性阻塞性肺病（COPD）
  • 囊肿纤维化
  • 其他用途
  • 全球干粉吸入器市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 居家照护环境
  • 门诊手术中心
  • 其他最终用户
  • 全球干粉吸入器市场：按单一吸入器类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 胶囊吸入器
  • 干粉吸入器
  • 全球干粉吸入器市场：按多剂量吸入器细分（按类型）、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 泡壳式吸入器
  • Rotaheler 吸入器

第七章 区域和国家分析

  • 全球干粉吸入器市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球干粉吸入器市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 干粉吸入器市场：竞争格局
  • 干粉吸入器市场：公司简介
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
    • GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
    • 3M Company Overview, Products and Services, Strategy and Financial Analysis
    • Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Viatris（Mylan NV）
  • Otsuka Pharmaceutical Co. Ltd
  • Sun Pharmaceutical Industries Limited
  • Catalent Inc.
  • Aptar Group Inc.
  • Chiesi Farmaceutici SpA
  • Recipharm AB
  • Cipla Limited
  • Lupin Limited
  • Orion Corporation
  • OPKO Health
  • Zhejiang Hisun Pharmaceutical Co Ltd
  • Beximco Pharmaceuticals Ltd
  • Sava Healthcare Ltd.
  • Hovione

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年干粉吸入器市场：提供新机会的国家
  • 2029年干粉吸入器市场：细分市场带来新机会
  • 2029年干粉吸入器市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r27950u

A dry powder inhaler (DPI) is a medical device designed for delivering medication in the form of dry powder directly to the lungs. It is primarily used for treating respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). To effectively use a DPI, it is crucial for the user to inhale rapidly and deeply, allowing the medication to reach the lungs.

The main types of dry powder inhalers include single-dose inhalers and multi-dose inhalers. Single-dose inhalers are devices that administer medication directly to the lungs in the form of dry powder. These devices can be either manually operated or digitally operated, and they find applications in treating conditions such as asthma, COPD, cystic fibrosis, and others. Various end-users, including hospitals and clinics, homecare settings, and ambulatory surgical centers, utilize these inhalers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The dry powder inhaler market research report is one of a series of new reports from The Business Research Company that provides dry powder inhaler market statistics, including dry powder inhaler industry global market size, regional shares, competitors with a dry powder inhaler market share, detailed dry powder inhaler market segments, market trends and opportunities, and any further data you may need to thrive in the dry powder inhaler industry. This dry powder inhaler market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dry powder inhaler market size has grown steadily in recent years. It will grow from $21.25 billion in 2024 to $22.18 billion in 2025 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to renewed interest in sustainable building materials, cultural preservation and heritage restoration, rise in green building practices, local sourcing and community involvement, regulatory support and building codes.

The dry powder inhaler market size is expected to see steady growth in the next few years. It will grow to $26.82 billion in 2029 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to continued emphasis on sustainability, global urbanization trends, advancements in manufacturing processes, government incentives and policies, global economic factors. Major trends in the forecast period include increased research and development, renewed interest in traditional building techniques, advancements in material technology, architectural and design trends, regulatory support for sustainable construction.

The forecast of 4.9% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on precision dose counters and breath-actuated dispersion mechanisms, sourced from key regions such as Germany and the UK, which could lead to compromised respiratory drug delivery and higher costs for chronic obstructive pulmonary disease (COPD) and asthma management.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of respiratory diseases is anticipated to boost the growth of the dry powder inhaler market in the future. Respiratory diseases encompass a wide range of disorders affecting the respiratory system, including various lung diseases. Dry powder inhalers play a critical role in treating respiratory conditions such as asthma, COPD, and cystic fibrosis by delivering medication directly to the lungs, where it is most effective. This method serves as a promising alternative to traditional drug delivery techniques for respiratory issues. For example, a study published in December 2023 by JAMA Network Open, a medical journal of the American Medical Association, indicates that the global burden of chronic obstructive pulmonary disease (COPD) is projected to nearly reach 600 million cases worldwide by 2050, reflecting a 23% increase in prevalence. Notably, cases among females are expected to surge by 47.1%, while male cases are projected to rise by only 9.4%. Additionally, the majority of these cases are expected to occur in low- and middle-income regions, where the prevalence is anticipated to be more than double that of high-income areas by 2050. Consequently, the growing prevalence of respiratory diseases will significantly drive the expansion of the dry powder inhaler market.

The increasing levels of air pollution are also anticipated to contribute to the growth of the dry powder inhaler market. Air pollution, measured by the concentration of various pollutants in the atmosphere, leads to respiratory issues, making dry powder inhalers a preferred delivery method for medications that alleviate symptoms and manage respiratory conditions exacerbated by airborne pollutants. In 2022, the United States Environmental Protection Agency reported approximately 66 million tons of pollutants released into the atmosphere in the United States. Additionally, in March 2023, IQAir reported that Iraq was the second most polluted country with 80.1 µg/m3, 16 times higher than the WHO PM2.5 annual guideline in 2022. Therefore, the rising levels of air pollution are expected to drive the growth of the dry powder inhaler market.

Key players in the dry powder inhaler market are focusing on developing innovative products featuring muscarinic antagonists for the treatment of chronic obstructive pulmonary disease (COPD) while also expanding their product portfolios. Muscarinic antagonists are drugs that inhibit the muscarinic acetylcholine receptor, and they are used to manage various conditions, including COPD and organophosphate poisoning. For example, in March 2024, Berry Global, a US-based company recognized for its development and manufacturing of diverse flexible packaging solutions, unveiled its new dry powder inhaler at Pharma Pack. This inhaler is specifically designed to improve drug delivery for respiratory conditions such as COPD and asthma, providing a customizable solution for pharmaceutical companies.

In August 2024, Aptar Pharma, a US-based specialist in drug delivery, acquired the Orbital Dry Powder Inhaler for an undisclosed sum. This acquisition strengthens Aptar's capabilities in respiratory drug delivery, especially for managing conditions such as asthma and chronic obstructive pulmonary disease (COPD). The Orbital Dry Powder Inhaler is noted for its innovative design, which enhances medication delivery. This acquisition aligns with Aptar Pharma's strategy to expand its product offerings and reinforce its position in the respiratory treatment market. The Orbital DPI operates within the pharmaceutical and medical device sectors in India.

Major companies operating in the dry powder inhaler market report are Novartis AG, AstraZeneca plc., GlaxoSmithKline PLC, 3M Company, Boehringer Ingelheim GmbH, Viatris (Mylan N.V), Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Catalent Inc., Aptar Group Inc., Chiesi Farmaceutici S.p.A., Recipharm AB, Cipla Limited, Lupin Limited, Orion Corporation, OPKO Health, Zhejiang Hisun Pharmaceutical Co Ltd., Beximco Pharmaceuticals Ltd., Sava Healthcare Ltd., Hovione, Elpen S.A., MannKind Corporation, Meda Pharmaceuticals, Presspart Manufacturing Ltd., SMB Laboratories SA, Teva Pharmaceutical Industries Limited, Pharmaxis Ltd., Iconovo AB, SRS Pharmaceuticals Pvt. Ltd.

North America was the largest region in the dry powder inhaler market in 2024. The regions covered in the dry powder inhaler market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the Dry Powder Inhaler market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dry powder inhaler market consists of sales of dry powder forms, spiriva handihalers, breath-activated inhalers, rotahalers, diskus devices, and twisthaler inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dry Powder Inhaler Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dry powder inhaler market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dry powder inhaler ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dry powder inhaler market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Single-Dose Inhalers; Multi-Dose Inhalers
  • 2) By Function: Manually Operated Inhaler Devices; Digitally Operated Inhaler Devices
  • 3) By Application: Asthma; Chronic Obstructive Pulmonary Disease (COPD); Cystic Fibrosis; Other Applications
  • 4) By End User: Hospitals And Clinics; Homecare Settings; Ambulatory Surgical Centers; Other End Users
  • Subsegments:
  • 1) By Single-Dose Inhalers: Capsule-Based Inhalers; Diskus-Based Inhalers
  • 2) By Multi-Dose Inhalers: Blister-Based Inhalers; Rotahaler-Based Inhalers
  • Companies Mentioned: Novartis AG; AstraZeneca plc.; GlaxoSmithKline Plc; 3M Company; Boehringer Ingelheim GmbH; Viatris (Mylan N.V); Otsuka Pharmaceutical Co. Ltd; Sun Pharmaceutical Industries Limited; Catalent Inc.; Aptar Group Inc.; Chiesi Farmaceutici S.p.A.; Recipharm AB; Cipla Limited; Lupin Limited; Orion Corporation; OPKO Health; Zhejiang Hisun Pharmaceutical Co Ltd; Beximco Pharmaceuticals Ltd; Sava Healthcare Ltd.; Hovione; Elpen S.A.; MannKind Corporation; Meda Pharmaceuticals; Presspart Manufacturing Ltd; SMB Laboratories SA; Teva Pharmaceutical Industries Limited; Pharmaxis Ltd.; Iconovo AB; SRS Pharmaceuticals Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Dry Powder Inhaler Market Characteristics

3. Dry Powder Inhaler Market Trends And Strategies

4. Dry Powder Inhaler Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Dry Powder Inhaler Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Dry Powder Inhaler PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Dry Powder Inhaler Market Growth Rate Analysis
  • 5.4. Global Dry Powder Inhaler Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Dry Powder Inhaler Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Dry Powder Inhaler Total Addressable Market (TAM)

6. Dry Powder Inhaler Market Segmentation

  • 6.1. Global Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Dose Inhalers
  • Multi-Dose Inhalers
  • 6.2. Global Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Manually Operated Inhaler Devices
  • Digitally Operated Inhaler Devices
  • 6.3. Global Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis
  • Other Applications
  • 6.4. Global Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Homecare Settings
  • Ambulatory Surgical Centers
  • Other End Users
  • 6.5. Global Dry Powder Inhaler Market, Sub-Segmentation Of Single-Dose Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Capsule-Based Inhalers
  • Diskus-Based Inhalers
  • 6.6. Global Dry Powder Inhaler Market, Sub-Segmentation Of Multi-Dose Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blister-Based Inhalers
  • Rotahaler-Based Inhalers

7. Dry Powder Inhaler Market Regional And Country Analysis

  • 7.1. Global Dry Powder Inhaler Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Dry Powder Inhaler Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Dry Powder Inhaler Market

  • 8.1. Asia-Pacific Dry Powder Inhaler Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Dry Powder Inhaler Market

  • 9.1. China Dry Powder Inhaler Market Overview
  • 9.2. China Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Dry Powder Inhaler Market

  • 10.1. India Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Dry Powder Inhaler Market

  • 11.1. Japan Dry Powder Inhaler Market Overview
  • 11.2. Japan Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Dry Powder Inhaler Market

  • 12.1. Australia Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Dry Powder Inhaler Market

  • 13.1. Indonesia Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Dry Powder Inhaler Market

  • 14.1. South Korea Dry Powder Inhaler Market Overview
  • 14.2. South Korea Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Dry Powder Inhaler Market

  • 15.1. Western Europe Dry Powder Inhaler Market Overview
  • 15.2. Western Europe Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Dry Powder Inhaler Market

  • 16.1. UK Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Dry Powder Inhaler Market

  • 17.1. Germany Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Dry Powder Inhaler Market

  • 18.1. France Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Dry Powder Inhaler Market

  • 19.1. Italy Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Dry Powder Inhaler Market

  • 20.1. Spain Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Dry Powder Inhaler Market

  • 21.1. Eastern Europe Dry Powder Inhaler Market Overview
  • 21.2. Eastern Europe Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Dry Powder Inhaler Market

  • 22.1. Russia Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Dry Powder Inhaler Market

  • 23.1. North America Dry Powder Inhaler Market Overview
  • 23.2. North America Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Dry Powder Inhaler Market

  • 24.1. USA Dry Powder Inhaler Market Overview
  • 24.2. USA Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Dry Powder Inhaler Market

  • 25.1. Canada Dry Powder Inhaler Market Overview
  • 25.2. Canada Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Dry Powder Inhaler Market

  • 26.1. South America Dry Powder Inhaler Market Overview
  • 26.2. South America Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Dry Powder Inhaler Market

  • 27.1. Brazil Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Dry Powder Inhaler Market

  • 28.1. Middle East Dry Powder Inhaler Market Overview
  • 28.2. Middle East Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Dry Powder Inhaler Market

  • 29.1. Africa Dry Powder Inhaler Market Overview
  • 29.2. Africa Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Dry Powder Inhaler Market Competitive Landscape And Company Profiles

  • 30.1. Dry Powder Inhaler Market Competitive Landscape
  • 30.2. Dry Powder Inhaler Market Company Profiles
    • 30.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. 3M Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Dry Powder Inhaler Market Other Major And Innovative Companies

  • 31.1. Viatris (Mylan N.V)
  • 31.2. Otsuka Pharmaceutical Co. Ltd
  • 31.3. Sun Pharmaceutical Industries Limited
  • 31.4. Catalent Inc.
  • 31.5. Aptar Group Inc.
  • 31.6. Chiesi Farmaceutici S.p.A.
  • 31.7. Recipharm AB
  • 31.8. Cipla Limited
  • 31.9. Lupin Limited
  • 31.10. Orion Corporation
  • 31.11. OPKO Health
  • 31.12. Zhejiang Hisun Pharmaceutical Co Ltd
  • 31.13. Beximco Pharmaceuticals Ltd
  • 31.14. Sava Healthcare Ltd.
  • 31.15. Hovione

32. Global Dry Powder Inhaler Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dry Powder Inhaler Market

34. Recent Developments In The Dry Powder Inhaler Market

35. Dry Powder Inhaler Market High Potential Countries, Segments and Strategies

  • 35.1 Dry Powder Inhaler Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Dry Powder Inhaler Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Dry Powder Inhaler Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer